Cephalosporins are bactericidal antibiotics and act by inhibiting cell wall synthesis. They inhibit a wide variety of gram-positive and gram-negative bacteria. They are considered broad-spectrum antibiotics with similar activities to those of ampicillin.
They are sometimes grouped into "generations" by their antimicrobial properties. Cephalosporin drugs can be grouped into five classes or generations. The gram-negative antimicrobial property significantly increases with each newer generation of cephalosporin. The report analysts forecast the global cephalosporin drugs market to grow at a CAGR of 3.21% over the period 2014-2019.
Covered in this report:
In this report, it covers the present scenario and growth prospects of the global cephalosporin drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various prescription drugs along with the generic drugs used for the treatment of various infectious diseases caused by the different strains of bacteria.
Global Cephalosporin Drugs Market has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global cephalosporin drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
To request sample Copy of This Report:
http://www.radiantinsights.com/research/global-cephalosporin-drugs-market-2015-2019#tabs-4
Key regions
They are sometimes grouped into "generations" by their antimicrobial properties. Cephalosporin drugs can be grouped into five classes or generations. The gram-negative antimicrobial property significantly increases with each newer generation of cephalosporin. The report analysts forecast the global cephalosporin drugs market to grow at a CAGR of 3.21% over the period 2014-2019.
Covered in this report:
In this report, it covers the present scenario and growth prospects of the global cephalosporin drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various prescription drugs along with the generic drugs used for the treatment of various infectious diseases caused by the different strains of bacteria.
Global Cephalosporin Drugs Market has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global cephalosporin drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
To request sample Copy of This Report:
http://www.radiantinsights.com/research/global-cephalosporin-drugs-market-2015-2019#tabs-4
Key regions
- Americas
- APAC
- EMEA
Key vendors
- Allergan
- Astellas
- Bristol-Myers Squibb
- GlaxoSmithKline
- Merck
- Pfizer
- Sandoz
- Teva Pharmaceuticals
Other prominent vendors
- Abbott
- Aspen Pharmacare
- AstraZeneca
- Aurobindo Pharma
- Basilea Pharmaceuticals
- Baxter
- Biocon
- Corden Pharma
- Cornerstone Therapeutics
- Eli Lilly
- F. Hoffmann-La Roche
- Flynn Pharma
- Hospira
- Incepta Pharmaceuticals
- johnson & johnson
- Kyorin Pharmaceutical
- Lupin Pharmaceuticals
- Orchid Pharma
- Par Pharmaceutical
- Pernix Therapeutics
- Sanofi
- Shionogi
- Sun Pharmaceutical
- Takeda Pharma
- Theravance Biopharma
- Wockhardt
Market driver
- Special regulatory designation for pipeline molecules
- For a full, detailed list, view our report
Market challenge
- Development of drug resistance
- For a full, detailed list, view our report
Market trend
- Use of combination therapies
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key Market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
No comments:
Post a Comment